Actinium Pharmaceuticals, Inc. (ATNM)

NYSEAMERICAN: ATNM · IEX Real-Time Price · USD
5.42 0.07 (1.31%)
Jan 24, 2022 4:00 PM EST - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year2020201920182017201620152014201320122011
Selling, General & Admin
6.315.526.739.199.0211.2710.183.484.512.96
Research & Development
16.0916.5517.0917.7217.8313.512.273.113.440.32
Other Operating Expenses
000000.050.040.0100
Operating Expenses
22.3922.0723.8326.9126.8524.8322.486.597.953.28
Operating Income
-22.39-22.07-23.83-26.91-26.85-24.83-22.48-6.59-7.95-3.28
Interest Expense / Income
0000.01-0.010.01001.10.18
Other Expense / Income
-0.18-0.17-0.17-0.31-2.52-3.812.214.18-0.69-0.01
Pretax Income
-22.22-21.9-23.65-26.6-24.32-21.03-24.69-10.77-8.36-3.44
Net Income
-22.22-21.9-23.65-26.6-24.32-21.03-24.69-10.77-8.36-3.44
Preferred Dividends
0000000000
Net Income Common
-22.22-21.9-23.65-26.6-24.32-21.03-24.69-10.77-8.36-3.44
Shares Outstanding (Basic)
12542211100
Shares Outstanding (Diluted)
12542211100
Shares Change
143.87%40.77%58.87%37.73%27.01%39.45%20.27%1961.81%37.63%-
EPS (Basic)
-1.83-4.40-6.60-12.00-15.00-16.50-27.00-14.10-227.40-129.00
EPS (Diluted)
-1.83-4.40-6.60-12.00-15.00-16.50-27.00-14.10-227.40-129.00
Free Cash Flow Per Share
-1.80-4.33-5.85-9.70-12.91-14.62-15.90-8.32-141.78-19.37
EBITDA
-21.77-21.48-23.6-26.54-24.25-20.96-24.65-10.77-7.26-3.27
EBIT
-22.22-21.9-23.65-26.6-24.33-21.02-24.69-10.77-7.26-3.27
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).